Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic literature without systematic search or primary human data
PubMed 23468190 · doi:10.1002/da.22084
What was done
Narrative review synthesizing mechanisms by which inflammatory cytokines and signaling pathways access the brain to alter central neurotransmitter metabolism (serotonin, dopamine, and glutamate) and neural circuits such as the basal ganglia and anterior cingulate cortex.
What was found
The abstract reports no numerical findings or quantitative statistics. It describes qualitatively that cytokines affect neurotransmitter synthesis, release, and reuptake via pathways such as p38 mitogen-activated protein kinase, activate the kynurenine pathway to deplete tryptophan and produce neuroactive metabolites, and alter basal ganglia and anterior cingulate neurocircuits involved in motor activity, motivation, anxiety, and arousal.
Why it matters
The paper outlines a mechanistic and evolutionary model connecting peripheral inflammatory cytokine signaling to the neurochemical and circuit alterations implicated in depression and anxiety.
Limits
This is a narrative review with no primary experimental or clinical data, sample size, or quantitative metrics reported in the abstract. It lacks a systematic review methodology, preventing formal assessment of study quality, selection bias, or effect sizes in humans.
Cited by
- context High levels of inflammation inhibit the presynaptic release of serotonin.